Role of nitric oxide in the regulation of myocardial function

J M Hare1, W S Colucci

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Insights

Nitric oxide (NO) impacts heart function by influencing contractility and heart rate. Excessive NO can cause cardiac dysfunction, while basal NO production offers protective effects.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology

Background:

  • Nitric oxide (NO) is produced by constitutive (cNOS) and inducible (iNOS) NO synthase isoforms.
  • NO influences myocardial contractility and heart rate, affecting beta-adrenergic responses.

Purpose of the Study:

  • To explore the role of NO in normal cardiac physiology and disease states.
  • To elucidate the mechanisms of NO's cardiac actions, including its effects on beta-adrenergic stimulation and calcium currents.

Main Methods:

  • Review of studies using NO donors, NOS inhibitors, and immune stimulation.
  • Biochemical, immunocytochemical, and molecular biological techniques to detect NOS isoforms in the myocardium.

Main Results:

  • Basal NO (via cNOS) mildly inhibits beta-adrenergic responses.
  • Excessive NO (via iNOS) contributes to myocardial depression in conditions like sepsis and dilated cardiomyopathy.
  • NO mediates parasympathetic slowing of heart rate and inhibits beta-adrenergic contractility, partly via cyclic guanosine monophosphate (cGMP).

Conclusions:

  • NO plays a dual role in cardiac function, with basal levels being protective and excessive levels detrimental.
  • Understanding NO's cardiac pathways is crucial for managing heart dysfunction in various diseases.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...